FDA Approves Skyclarys (omaveloxolone) for the Treatment of Friedreich ’s Ataxia

PLANO, Texas--(BUSINESS WIRE) February 28, 2023 -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the“Company,”“our,”“us,” or“we”), a biopharmaceutical company focused on...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news